亨廷顿病精神与认知症状的遗传风险基础
该研究在5160例亨廷顿病患者中检验精神与认知症状是否受与一般人群相同的常见遗传变异影响。结果显示,重度抑郁症多基因风险评分与亨廷顿病抑郁风险相关,精神分裂症风险评分与精神病性症状及易激惹相关,认知损害与淡漠则与智力多基因风险评分降低相关。
要点
- 重度抑郁症多基因风险评分与亨廷顿病抑郁风险相关。
- 精神分裂症风险评分与亨廷顿病精神病性症状及易激惹相关。
- 认知损害与淡漠和智力多基因风险评分降低相关,遗传基础可能不同。
核心结论
- 精神疾病多基因风险评分尤其抑郁与精神分裂症评分与亨廷顿病相应精神症状风险增加相关,提示共同遗传易感性。
- 亨廷顿病认知损害与淡漠的遗传易感性似乎与其他精神症状不同。
- 亨廷顿病症状与其他神经退行性疾病风险评分未观察到关联。
研究设计与样本
- 研究构建了精神疾病、神经退行性疾病及智力的多基因风险评分,并在5160例亨廷顿病患者中检验其与精神及认知症状的相关性。
主要发现
- 重度抑郁症多基因风险评分与亨廷顿病抑郁风险增加相关。
- 精神分裂症风险评分与亨廷顿病精神病性症状及易激惹相关。
- 认知损害与淡漠与智力多基因风险评分降低相关。
- 亨廷顿病症状与其他神经退行性疾病风险评分无关联。
关键数值与推荐
- 样本量为5160例亨廷顿病患者。
临床怎么用
- 数据为对抑郁和精神分裂症有效的治疗用于亨廷顿病抑郁及精神病性症状提供了依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Huntington's disease (HD) is an inherited neurodegenerative disorder caused by an expanded CAG repeat in the HTT gene. It is diagnosed following a standardized examination of motor control and often presents with cognitive decline and psychiatric symptoms. Recent studies have detected genetic loci modifying the age at onset of motor symptoms in HD, but genetic factors influencing cognitive and psychiatric presentations are unknown. METHODS: We tested the hypothesis that psychiatric and cognitive symptoms in HD are influenced by the same common genetic variation as in the general population by 1) constructing polygenic risk scores from large genome-wide association studies of psychiatric and neurodegenerative disorders and of intelligence and 2) testing for correlation with the presence of psychiatric and cognitive symptoms in a large sample (n = 5160) of patients with HD. RESULTS: Polygenic risk score for major depression was associated specifically with increased risk of depression in HD, as was schizophrenia risk score with psychosis and irritability. Cognitive impairment and apathy were associated with reduced polygenic risk score for intelligence. CONCLUSIONS: Polygenic risk scores for psychiatric disorders, particularly depression and schizophrenia, are associated with increased risk of the corresponding psychiatric symptoms in HD, suggesting a common genetic liability. However, the genetic liability to cognitive impairment and apathy appears to be distinct from other psychiatric symptoms in HD. No associations were observed between HD symptoms and risk scores for other neurodegenerative disorders. These data provide a rationale for treatments effective in depression and schizophrenia to be used to treat depression and psychotic symptoms in HD.
引用
- Ellis N, Tee A, McAllister B, et al. Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease. Biol Psychiatry. 2019. PMID: 32087949. doi:10.1016/j.biopsych.2019.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。